跳至主要内容
临床试验/CTRI/2018/12/016723
CTRI/2018/12/016723尚未招募未知

ROLE OF SPOT URINE SODIUM IN FUROSEMIDE STRESS TEST IN VOLUME OVERLOADED CRITICALLY ILL PATIENTS WITH ACUTE KIDENY INJURY

AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Acute kidney injury (AKI) - AKIN stage 1 and 2
  • 2 Systolic BP > 100 mm Hg with or without vasopressors
  • 3 Patients on norepinephrine infusion < 10 mcg per minute dose requirement

排除标准

  • 1 Pre existing CKD
  • 2 AKI- AKIN stage 3
  • 3 Significant Heart diseases including cardiac failure
  • 4 Chronic liver disease
  • 5 Significant hemodynamic instability
  • 6 Hypotension SBP < 100 mm Hg with or without vasopressors
  • 7 Patients on norepinephrine infusion > 10 mcg per minute dose requirement
  • 8 Patients requiring 2 or more vasopressors
  • 9 Major electrolyte disturbances
  • 10 Na < 120, > 160 mmol/L
  • 11 DI, SIADH and other major disorders affecting serum Na levels

研究者

发起方
AIIMS New Delhi

相似试验

ROLE OF SPOT URINE SODIUM IN FUROSEMIDE STRESS TEST... | 临床试验